Bionomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 112.3%.

Top 15 shareholders own 22.4% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.49%	Armistice Capital LLC	1,296,486	€256.3k	5.68%	0.01%
5.91%	Apeiron Investment Group	1,024,309	€202.5k	-46%	0.36%
3.46%	Lynx1 Capital Management LP	599,673	€118.6k	-26.4%	0.06%
2.99%	Presight Capital	518,717	€102.5k	-34.4%	1.17%
1.82%	Point72 Asset Management, L.P.	316,000	€62.5k	0%	no data
0.2%	UBS Asset Management AG	34,897	€6.9k	251%	no data
0.15%	Two Sigma Securities, LLC, Asset Management Arm	26,038	€5.1k	0%	no data
0.13%	Lewis Asset Management, LLC	23,000	€4.5k	53.3%	no data
0.095%	Two Sigma Investments, LP	16,370	€3.2k	-4.1%	no data
0.063%	XTX Holdings Limited, Asset Management Arm	10,940	€2.2k	0%	no data
0.058%	Beacon Pointe Advisors, LLC	10,000	€2.0k	0%	no data
0.013%	Rhumbline Advisers Ltd Partnership	2,195	€433.8	68.2%	no data
0.0046%	Morgan Stanley, Investment Banking and Brokerage Investments	794	€156.8	745%	no data
0.0011%	Aspire Private Capital, LLC	200	€39.4	0%	no data
0.00001%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€0.3	0%	no data